CbdMD Inc (YCBD)

cbdMD, Inc. is a common stock listing on the NYSE under the symbol YCBD. The company develops, markets, and distributes cannabidiol-based consumer products in the United States and international markets. Its portfolio includes CBD oils, gummies, capsules, soft-gels, topicals, and functional formulations under the cbdMD brand, along with hemp-derived compliant Delta-9 THC products. Through Paw CBD, it also sells products for dogs and cats, including tinctures, chews, and topicals. Additional offerings include non-cannabinoid functional ingredients under the ATRx brand and hemp-derived solutions under Herbal Oasis. cbdMD serves retailers and health and pet channels through direct-to-consumer sales, e-commerce platforms, online marketplaces, and wholesale distribution. The company is based in Charlotte, North Carolina, and previously operated under the name Level Brands, Inc. before adopting the cbdMD name in May 2019.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-YCBD
$0.76
32.7% Upside
Undervalued
$2
247.8% Upside
Bargain
Fair
0.0%
August 19, 2026
-1.9x
0.6x
0.3x
5.979 M
3.073 M
6.5%
97.2%
-22.6
85.4%
Valuation • Fair Value

cbdMD Inc (NYSE-YCBD) Fair Value by Valuation Model

Compare the primary fair value estimate for cbdMD Inc (NYSE-YCBD) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.76

Estimated upside of 32.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.76

Comparable-company valuation reference.

Analyst Price Target

$2

Analysts imply upside of 247.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for cbdMD Inc (NYSE-YCBD) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for cbdMD Inc (NYSE-YCBD)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

19.985 M

Current operating scale indicator.

Revenue Forecast

22.153 M

Forward revenue estimate.

EBITDA

-1.638 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review cbdMD Inc (NYSE-YCBD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for cbdMD Inc (NYSE-YCBD)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-2.10

Intermediate zone that deserves monitoring.

Altman Z-Score

-22.6

Lower score that deserves closer risk review.

FCF / Net Income

85.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for cbdMD Inc (NYSE-YCBD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for cbdMD Inc (NYSE-YCBD)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 19, 2026

Days to Earnings

29

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for cbdMD Inc (NYSE-YCBD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

cbdMD Inc (NYSE-YCBD) Stock Forecast & Technical Outlook

Review cbdMD Inc (NYSE-YCBD) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for cbdMD Inc (NYSE-YCBD) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for cbdMD Inc (NYSE-YCBD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for cbdMD Inc (NYSE-YCBD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for cbdMD Inc (NYSE-YCBD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for cbdMD Inc (NYSE-YCBD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for cbdMD Inc (NYSE-YCBD)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for cbdMD Inc (NYSE-YCBD) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

cbdMD Inc (NYSE-YCBD) Stock FAQ

Quick answers about cbdMD Inc (NYSE-YCBD) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.76
Estimated upside 32.7%
Valuation Rating
Undervalued
Estimated upside of 32.7%
Analyst Target
$2
Implied upside 247.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for cbdMD Inc (NYSE-YCBD) is $0.76. This implies an estimated upside of 32.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 32.7% versus the current market price.

The available analyst price target for cbdMD Inc (NYSE-YCBD) is $2. The analyst target implies estimated upside of 247.8%.

The current financial health read for cbdMD Inc (NYSE-YCBD) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for cbdMD Inc (NYSE-YCBD) is August 19, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for cbdMD Inc (NYSE-YCBD) is -1.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for cbdMD Inc is 5.979 M.

The current enterprise value listed for cbdMD Inc is 3.073 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for cbdMD Inc is NYSE-YCBD, and the stock is listed on NYSE.

cbdMD Inc (NYSE-YCBD) is listed on NYSE.

The current debt-to-total-capital ratio listed for cbdMD Inc is 6.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for cbdMD Inc is 97.2%. Free float helps investors understand how much of the share base is available for public trading.